First Time Loading...

Ergomed PLC
LSE:ERGO

Watchlist Manager
Ergomed PLC Logo
Ergomed PLC
LSE:ERGO
Watchlist
Price: 1 346 GBX Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

The Relative Value of one ERGO stock under the Base Case scenario is 1 623.57 GBX. Compared to the current market price of 1 346 GBX, Ergomed PLC is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ERGO Relative Value
Base Case
1 623.57 GBX
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.5
P/S
P/S
Price to Sales
4.5
vs History
36
vs Industry
42
Median 3Y
4.5
Median 5Y
4.5
Industry
3.9
Forward
4.1
More Details
45.6
P/E
P/E
Price to Earnings
45.6
vs History
34
vs Industry
10
Median 3Y
45.6
Median 5Y
43.9
Industry
31.1
Forward
28.5
More Details
35.5
P/OCF
P/OCF
Price to OCF
35.5
vs History
34
vs Industry
14
Median 3Y
35.5
Median 5Y
34.9
Industry
23.3
More Details
49
P/FCFE
P/FCFE
Price to FCFE
49
vs History
28
vs Industry
14
Median 3Y
46.4
Median 5Y
43
Industry
27.4
More Details
7.5
P/B
P/B
Price to Book Value
7.5
vs History
41
vs Industry
8
Median 3Y
7.6
Median 5Y
7.5
Industry
2.5
More Details
4.3
EV/S
EV/S
Enterprise Value to Sales
4.3
vs History
36
vs Industry
40
Median 3Y
4.3
Median 5Y
4.3
Industry
3.8
Forward
4
More Details
10.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.6
vs History
31
vs Industry
34
Median 3Y
10.7
Median 5Y
10.5
Industry
7.9
More Details
25.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.1
vs History
30
vs Industry
16
Median 3Y
25.1
Median 5Y
23.3
Industry
17.2
Forward
19.9
More Details
31.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
31.8
vs History
30
vs Industry
15
Median 3Y
31.7
Median 5Y
30.5
Industry
22.7
Forward
23.7
More Details
34.2
EV/OCF
EV/OCF
Enterprise Value to OCF
34.2
vs History
33
vs Industry
16
Median 3Y
34.2
Median 5Y
33.6
Industry
21.4
More Details
39.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
39.2
vs History
28
vs Industry
18
Median 3Y
39
Median 5Y
37.6
Industry
27.9
More Details
6.4
EV/IC
EV/IC
Enterprise Value to IC
6.4
vs History
34
vs Industry
13
Median 3Y
6.4
Median 5Y
6.1
Industry
2.4
More Details

Multiples Across Competitors

ERGO Competitors Multiples
Ergomed PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Ergomed PLC
LSE:ERGO
683.5m GBP 4.5 45.6 25.1 31.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.3B USD 5.2 36.9 22.8 33.4
US
Danaher Corp
NYSE:DHR
184B USD 4.2 22.8 16.6 20.4
CH
Lonza Group AG
SIX:LONN
37.5B CHF 5.6 57.3 19.7 28.9
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.7 29.9 16.3 25.2
US
Agilent Technologies Inc
NYSE:A
40.9B USD 6.1 33.1 26.4 31.8
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.2 23.9 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.6B USD 9.1 46.9 32.5 39.5
IE
ICON PLC
NASDAQ:ICLR
25.6B USD 3.1 37.4 16.9 26
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
ERGO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ERGO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ERGO stock valuation using valuation multiples.
Wall Street Estimates
ERGO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ERGO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.